Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Interest & Investment Income: 2015-2024

Historic Interest & Investment Income for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Dec 2024 value amounting to $8.3 million.

  • Rocket Pharmaceuticals' Interest & Investment Income fell 46.57% to $709,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 44.47%. This contributed to the annual value of $8.3 million for FY2024, which is 56.34% up from last year.
  • According to the latest figures from FY2024, Rocket Pharmaceuticals' Interest & Investment Income is $8.3 million, which was up 56.34% from $5.3 million recorded in FY2023.
  • In the past 5 years, Rocket Pharmaceuticals' Interest & Investment Income ranged from a high of $8.3 million in FY2024 and a low of $2.1 million during FY2020.
  • Over the past 3 years, Rocket Pharmaceuticals' median Interest & Investment Income value was $5.3 million (recorded in 2023), while the average stood at $5.8 million.
  • Per our database at Business Quant, Rocket Pharmaceuticals' Interest & Investment Income crashed by 37.02% in 2020 and then spiked by 56.34% in 2024.
  • Over the past 5 years, Rocket Pharmaceuticals' Interest & Investment Income (Yearly) stood at $2.1 million in 2020, then skyrocketed by 42.70% to $3.1 million in 2021, then increased by 26.76% to $3.9 million in 2022, then surged by 35.97% to $5.3 million in 2023, then soared by 56.34% to $8.3 million in 2024.